As 2026 begins, the global regenerative medicine landscape is pivoting toward full-scale clinical integration, driven by new FDA and EMA frameworks for bio-ink standardization. Healthcare systems in North America and Western Europe are now moving past simple scaffold structures to functional, vascularized tissue transplants, marking a significant milestone for chronic wound care and...